Infinium Pharmachem IPO
Infinium Pharmachem Subscription Details
- Open Date 31 Mar
- Close Date 05 Apr
- Lot Size 1000
- IPO Size ₹ 25.26 Cr
- IPO Price Range ₹ 135
- Min Investment ₹ 135000
- Listing Exchange NSE SME
- Basis of Allotment 11 Apr
- Refunds 12 Apr
- Credit to Demat Account 13 Apr
- Listing Date 17 Apr
Infinium Pharmachem IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 31-Mar-23 | - | 0.06x | 0.10x | 0.08x |
| 3-Apr-23 | - | 0.33x | 0.61x | 0.47x |
| 5-Apr-23 | - | 1.80x | 1.86x1 | 1.84x |
Infinium Pharmachem IPO Synopsis
Infinium Pharmachem IPO opens on Mar 31, 2023, and closes on Apr 5, 2023. The issue entails fresh issue of 1,875,000 equity shares aggregating the issue size upto Rs. 25.31cr. The issue will be listed on SME NSE on 17th April while the shares will be allotted on 11th April. The company has set the lot size at 1000 shares per lot while the price is set at Rs. 135 per share. The leading book manager to the issue is Swatiska Investmart Ltd.
Objective of the Infinium Pharmachem IPO:
The net proceeds from the issue will be utilised towards:
1. Marketing and branding expenses (including registration in reach - Europe, and other marketing expenses)
2. Repayment of some of the existing loans and expansion of units
3. To meet incremental working capital requirements
4. To meet public issue expenses
About Infinium Pharmachem
The Company was incorporated with the objective of manufacturing and supplying of various pharma related chemicals, bulk drugs, pharma intermediates etc. It deals specifically and mainly in manufacturing and supplying of Iodine Derivatives, Pharma Intermediates and Active Pharmaceutical Ingredients (APIs).
The Company penetrated the pharmaceutical market with the CRAMS Model i.e., Contract Research & Manufacturing Services in which the Company emphasizes on:
1. Process Optimization
2. Developing / Manufacturing the products specifically as per customer's requirement and final application;
3. Customized Packing / Labelling
4. Reliable Supply of final product
5. Highly focused to Iodine Chemistry
The company’s manufacturing capabilities and technical expertise have efficiently catered numerous industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics and much more.
The Company currently provides the widest range of Iodine derivatives in the market, with more than 250+ intermediates and 15+ APIs.
Check Out Web-Stories on Infinium Pharmachem IPO
Infinium Pharmachem Financial Status
Profit and Loss
Balance Sheet
| Particulars (in Rs. Crores) | FY22 | FY21 | FY20 |
|---|---|---|---|
| Revenue from operations | 99.12 | 70.53 | 38.84 |
| EBITDA | 9.64 | 5.53 | 3.20 |
| PAT | 6.11 | 2.72 | 0.93 |
| Particulars (in Rs. Crores) | FY22 | FY21 | FY20 |
|---|---|---|---|
| Total Assets | 59.00 | 34.18 | 22.45 |
| Share Capital | 1.02 | 1.02 | 1.02 |
| Total Borrowings | 13.85 | 5.79 | 5.66 |
| Particulars (in Rs. Crores) | FY22 | FY21 | FY20 |
|---|---|---|---|
| Net cash generated from / (used in) operating activities | 11.80 | 7.29 | 3.03 |
| Net cash from / (used in) investing activities | -6.63 | -5.00 | -1.05 |
| Net cash flow from / (used in) financing activities | -1.70 | -1.16 | -1.24 |
| Net increase (decrease) in cash and cash equivalents | 3.46 | 1.13 | -1.24 |
Peer Comparison
| Name of the Company |
Revenue from operations (in Rs. crores) |
EBITDA | PAT Margin | Net Worth |
|---|---|---|---|---|
| Infinium Pharmachem Limited | 74.04 | 9.64 | 7.43% | 12.55 |
| Samrat Pharmachem Limited | 221.81 | 24.89 | 7.75% | 46.82 |
Infinium Pharmachem IPO Key Points
-
Strengths
1. Expanding reach to over 15+ countries across the globe while significantly increasing customer base in India too
2. The Company has a good quantity of competent raw material suppliers, which allows it to bypass many supply-chain bottlenecks
3. Professional and experience team including our in-house R&D and Quality Assurance departments
4. Competitive marketing Strategy garnering consistent growth in revenue
-
Risks
1. Domestic Sales are dependent on Top 5 States and export sales are majorly dependent on the China
2. Manufacturing process involves the use of hazardous and flammable industrial chemicals which entails significant risks and could also result in enhanced compliance obligations
3. reliant on third-party transportation service providers for the movement of raw materials and finished products
4. Any inability to compete effectively may lead to a lower market share or reduced operating margins.
How to apply for IPO?
-
Login to your 5paisa account and select the issue in the
current IPO section -
Enter the number of lots and price at which you wish to
apply for -
Enter your UPI ID and click on submit. With this, your
bid will be placed with the exchange -
You will receive a mandate notification to block funds in
your UPI app -
Approve the mandate request on your UPI and funds
will be blocked
Open account in 5 minutes
Be a part of the 5paisa community now with 10 million mobile app users
Please keep below documents handy:
- PAN Card
- Aadhar Card
- Bank Account Number
Infinium Pharmachem IPO FAQs
What is the price band of the Infinium Pharmachem IPO?
The price for the Infinium Pharmachem IPO is set at Rs. 135 per share.
When does the Infinium Pharmachem IPO issue open and close?
The Infinium Pharmachem IPO opens on 31st March and closes on 5th April.
What is the size of Infinium Pharmachem IPO ?
The IPO comprises of fresh issue of 1,875,000 equity shares aggregating the issue size upto Rs. 25.31cr.
What is the allotment date of Infinium Pharmachem IPO?
The allotment date of Infinium Pharmachem IPO is set for 11th April.
What is the Infinium Pharmachem IPO’s listing date?
The Infinium Pharmachem IPO will be listed on on 17th April.
What is the lot size and investment required for the Infinium Pharmachem IPO?
The Infinium Pharmachem IPO lot size is 1000 shares. A retail-individual investor can apply for up to 1 lots (1000 shares or ₹135,000).
What is the objective of the Infinium Pharmachem IPO?
The net proceeds from the issue will be used for:
1. Marketing and branding expenses (including registration in reach - Europe, and other marketing expenses)
2. Repayment of some of the existing loans and expansion of units
3. To meet incremental working capital requirements
4. To meet public issue expenses
How to apply for the Infinium Pharmachem IPO?
To apply for the IPO, follow the steps given below
· Login to your 5paisa account and select the issue in the current IPO section
· Enter the number of lots and price at which you wish to apply for
· Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange
Who are the book runners for Infinium Pharmachem IPO?
Unistone Capital Private Limited is the book running lead managers to the issue.
Who are the promoters/key personnels of Infinium Pharmachem IPO?
Infinium Pharmachem IPO is promoted by Mr. Mayank Shah.
Contact Details of Infinium Pharmachem IPO
Contact Information
Infinium Pharmachem Limited
38 G.I.D.C Sojitra,
Taluka - Sojitra,
Dist. - Anand - 387240
Phone: +91-2692-238849
Email: info@infiniumpharmachem.com
Website: https://infiniumpharmachem.com/
Infinium Pharmachem IPO Register
Swastika Investmart Ltd
Infinium Pharmachem IPO Lead Manager
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://www.bigshareonline.com/
s.webp)
.webp)
a.webp)